Blockchain Technology Market report forecasts revenue growth at global, regional & country levels and provides an analysis on the Industry Trends from 2015 to 2024

Global Blockchain Technology Market is expected to reach USD 7.74 billion by 2024, according to a new report by Grand View Research, Inc. Blockchain is the underlying technology that originated in the form of a public ledger to keep a track of all cryptocurrency transactions. The technology works as an electronic transaction-processing and record-keeping system. This allows various participants that are connected to the network, usually public, to track information through a secure network, thereby eliminating the need for any kind of third-party verification.

The increasing adoption of the technology in the financial services sector and expected adoption across the public sector and healthcare segments are few of the major factors that are expected to fuel the demand for the said market.
The market is expected to grow rapidly owing to numerous benefits that it provides, such as eradication of the requirement of a financial institution to validate transactions, reduce duplicative record keeping, eliminate reconciliation, minimize error rates, and facilitate faster settlement. With the use of the said technology, the databases could become universal in nature, thereby allowing multiple institutions to use it at the same time to bring various different systems closer together and help increase the efficiency.
The increasing demand for this technology across financial services, consumer or industrial products, technology, media & telecom, healthcare, transportation, and public sector is largely responsible for driving the market toward growth.

The major drivers include the growing interest of the BFSI sector and increasing merchants accepting crypto currencies among others. The probable opportunity of this technology further includes the instant settlement of various financial transactions and achieving optimized settlement options for the netting and clearing process.

Access for full detail of the Report: http://www.grandviewresearch.com/industry-analysis/blockchain-technology-market

Further key findings from the report suggest:

• Recently, investments have been made in the technology by various financial institutions in association with key technology players to further improve the efficiency of the underlying financial processes and help minimize the risk
• The technology will be able to support IoT applications, book keeping in the healthcare sector, instantaneous payments in the transportation segment, and maintenance of records for land ownership by the governments in the public sector.
• Some of the prominent vendors in the market include Chain Inc., Circle Internet Financial Limited, Digital Asset Holdings, Eric Industries, IBM Corporation, Linux Foundation, Post-Trade Distributed Ledger, R3, Ripple, and Safello.

Borrows all related Reports from same Category: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies 

Grand View Research has segmented the blockchain technology market has been segmented on the basis of type, application, and region:

Blockchain Technology Type Outlook (Revenue, USD Million; 2015 - 2024)

• Public
• Private
• Hybrid

Blockchain Technology Application Outlook (Revenue, USD Million; 2015 - 2024)

• Financial Services
• Consumer orIndustrial Products
• Technology, Media, and Telecom
• Healthcare
• Transportation
• Public Sector

Blockchain Technology Regional Outlook (Revenue, USD Million; 2015 - 2024)

• North America
• Europe
• Asia Pacific
• Rest of the World

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-blockchain-technology-market  
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Biomarkers Market Competitive Landscape by Strategic Framework and Market Participation Categorization

Global Biomarkers Market is expected to reach over USD 78.2 billion by 2024, according to a new report by Grand View Research, Inc. The growing demand for companion diagnostics and the rising adoption of personalized medicine are the key factors propelling the growth of the biomarkers market. The increasing need of disease-specific biomarkers for the development of diagnostics, the increasing R&D funding, and the rising prevalence of oncology and cardiovascular-based diseases are anticipated to create significant opportunities for the market growth during the forecast period.

The spiralling population and the upward trend in the adoption of sedentary lifestyles are expected to provide the industry with a huge target population base. Government grants and research funding for the discovery and development of novel biomarkers are the other factors accentuating the market growth. The introduction of the biomarker-based diagnostic kits for screening high-risk population coupled with the growing prevalence of genetic disorders is also anticipated to increase the client base for this market.

Access for full Detail of the Report: http://www.grandviewresearch.com/industry-analysis/biomarkers-industry

Further key findings from the study suggest:

• The safety biomarkers segment held the largest share of over 40% in 2015 owing to the increasing routine healthcare check-ups and the growing base of the geriatric population that is at a high risk of developing various diseases
• The validation biomarkers segment is determined as one of the fastest growing segments. The increasing R&D initiatives for the development of more specific biomarkers, and hence the subsequent development of companion diagnostics with enhanced accuracy and sensitivity for the effective detection of diseases are key factors contributing towards the aforementioned growth.
• The drug discovery segment dominated the application segment in 2015. Biomarkers are extensively used by pharmaceutical companies to accelerate the development of new drug findings and to predict the failure of the upcoming drugs.
• The diagnostic segment is estimated to witness a lucrative growth over the forecast period owing to the growing awareness about routine healthcare check-ups and the rising prevalence of various diseases
• In 2015, the oncology segment dominated with a revenue generated over USD 9.2 billion owing to the introduction of companion diagnostic tests for oncology drugs and the growing burden of cancer across the globe
• The cardiovascular segment is expected to be the fastest growing segment with a CAGR of over 14.0%. The growing adoption of sedentary lifestyles and the rise in the obese population base leading to cardiovascular diseases are estimated to provide this market with a potential growth platform.
• North America held the largest regional share of around 39% in 2015. The well-established R&D infrastructure and the high level of disposable income are the factors contributing towards the large market share.
• Asia Pacific is anticipated to be the fastest growing biomarker market owing to the factors, such as the developing economic conditions, a large base of the target population, and a favourable regulatory scenario for clinical trials.
• Major players include Roche Diagnostics Ltd., Abbott Laboratories, Inc., Agilent Technologies, Inc., Epigenomics AG, GE Healthcare, Johnson and Johnson, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH, Qiagen, Inc., Merck& Co., Inc., and others
• Market participants are ensuring stability by funding the growing R&D initiatives and focusing on the developing countries through the expansion and introduction of novel biomarker diagnostics. In 2015, Pfizer, Inc. developed a lung cancer therapy drug, Crizotinib used in non-small cell lung cancer therapy associated with ALK fusions.

Borrows all Related reports from same Category: http://www.grandviewresearch.com/industry/biotechnology 

Grand View Research has segmented the global biomarkers market on the basis of application, type, and region:

Global Biomarkers Type Outlook (Revenue, USD Million, 2014 - 2024)

• Safety
• Efficacy
• Validation

Global Biomarkers Application Outlook (Revenue, USD Million, 2014 - 2024)

• Diagnostic
• Drug Development 
•  Personalized Medicine
• Others

Global Biomarkers Disease Outlook (Revenue, USD Million, 2014 - 2024)

• Oncology
• Cardiovascular disease
• Neurological disease
• Immunological disease
• Others

Biomarkers Regional Outlook (Revenue, USD Million, 2014 - 2024)
North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Spain
• Italy

Asia Pacific

• Japan
• China
• India

Latin America

• Brazil
• Mexico

MEA

• South Africa

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-biomarkers-market 
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com
 

Radiation Dose Monitoring Market Variables, Trends and Scope 2014-2025

Global Radiation Dose Monitoring Market is anticipated to reach a value of USD 3.9 billion by 2025, according to a new report by Grand View Research, Inc. The advantage of automated dose monitoring systems to track individual and cumulative radiation dose exposure in patients is driving significant demand for the product.

Dose monitoring is achieved by the use of software and designated products such as dosimeters. Dose management software analyzes, identifies, and optimizes radiation dose performance with precise data. This data aids the physicians to provide quality care to the patients. Furthermore, easy integration of software into existing medical architecture of hospitals will boost the value of existing medical systems and ensure safety of using them.

Area of application commonly employing the use of medical imaging is radiography, angiography, mammography, fluoroscopy & interventional imaging and nuclear medicine. Several medical imaging technology manufacturers are constantly involving in the incorporation of the radiation dose monitoring tools in these imaging platforms. X-ray and computed tomography technique are known to emit a large amount of radiation as compared to other imaging platforms. The overall market exhibits promising growth prospects pertaining to high prevalence of chronic diseases, effective and reliable treatment methods focusing on care, and increasing patient awareness.

Access for full detail of the Report: http://www.grandviewresearch.com/industry-analysis/radiation-dose-monitoring-market

Further key findings from the study suggest:

• North America reported highest revenue growth in this market in 2015. A shift to the value based care delivery model has resulted in healthcare providers to divert their attention to deliver healthcare services concentrating on the well-being of a patient
• Asia Pacific region provides lucrative market opportunities for radiation dose monitoring. Significant factors such as rapid urbanization, upgrade in healthcare infrastructure and delivery will further support the market growth in emerging economies like India and China
• The market for radiation dose monitoring software is expected to generate strong revenue growth in the fiscal year 2015. The software market enables easy integration to existing architecture in healthcare facilities, and will sync into the integrated care delivery benefitting the specialists to provide better and monitored care
• The major market players recognized in this market are GE Healthcare, Sectra, Medicvision, Philips Healthcare, Toshiba MSC, Bayer AG, Landauer, Inc. and Thermo Fisher Scientific, Inc.

View all related reports from same category: http://www.grandviewresearch.com/industry/medical-devices 

Grand View Research has segmented the radiation dose monitoring market by component, application and product:

Component Outlook (Revenue, USD Million; 2014 - 2025)

• Software
• Service

Application Outlook (Revenue, USD Million; 2014 - 2025)

• Radiography
• Angiography
• Mammography
• Fluoroscopy & Interventional Imaging
• Others

Product Outlook (Revenue, USD Million; 2014 - 2025)

• Dosimeters
• Area Process Monitors
• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)
North America

• U.S.
• Canada

Europe

• Germany
• UK

Asia Pacific

• China
• Japan

Latin America

• Mexico
• Brazil

MEA

• South Africa
• Saudi Arabia

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-radiation-dose-monitoring-market 
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Botulinum Toxin Market Analysis 2013 and Forecast up to 2025

Global Botulinum Toxin (BNT) Market is expected to reach a value of USD 7.3 billion by 2025. The constant introduction of innovative products for enhancement of aesthetic appeal supporting minimally invasive aesthetic treatments is the prime factor driving the growth of the market.

In addition, rapid growth of the sector is attributed to the rising demand for minimally invasive or non-invasive procedures. These procedures provide advantages such as small incision, shorter hospital stay and rapid wound healing, and hence lead to larger acceptance and demand. In addition, availability of wide variety of minimally invasive or non-invasive treatment options is pushing the global botulinum toxin market towards growth.

Also, the successful completion of research projects is expected to expand the applications of presently approved products. Companies are trying to widen the application of botulinum toxin in therapeutic area through various research activities. For instance, Botox by Allergan received the U.S. FDA approval for the treatment of strabismus (crossed eyes) and blepharospasm associated with dystonia in 1989. Furthermore, in 2004, Botox was approved by the U.S. FDA for hyperidrosis, cervical dystonia, upper limb spasticity, chronic migraine and urinary incontinence in 2009, 2010 and 2011 respectively. Hence, these factors all together will aid in boosting the growth of BNT sales during the forecast period.

Access for the full detail of the Report: http://www.grandviewresearch.com/industry-analysis/botulinum-toxin-market

Further Key Findings from the Study Suggest:

• The rapid adoption of minimally invasive treatment is augmenting the growth of neurotoxins market.
• The botulinum toxin type A segment accounted for the largest share in 2015 and is also anticipated to be the fastest growing segment during the forecast period
• In 2015, North America dominated the global space with the largest revenue share owing to high demand for minimally invasive or non-invasive aesthetic treatments
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding anti-wrinkle procedures in India, China, and Japan
• Major players competing in this market include but are not limited to Allergan, Inc.; Ipsen Group; Merz GmbH and Co. KGaA, Medytox,Inc.; US Worldmed, LLC; Lanzhou Institute of Biological Products. Co.Ltd. and Revance Therapeutics, Inc.

View all the Related Reports from same Category: http://www.grandviewresearch.com/industry/pharmaceuticals 

Grand View Research has segmented the botulinum toxin market by type, end use, and region:

Product Type Outlook (Revenue, USD Million; 2013 - 2025)

• Botulinum Toxin Type A
• Botulinum Toxin Type B

End Use Outlook (Revenue, USD Million; 2013 - 2025)

• Therapeutic
• Aesthetic

Regional Outlook (Revenue, USD Million; 2013 - 2025)
North America

• U.S.
• Canada

Europe

• Germany
• UK

Asia Pacific

• China
• Japan

Latin America

• Mexico
• Brazil

MEA

• South Africa

Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-botulinum-toxin-market 
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

BIPV and BIOPV Market Variables, Trends and Scope 2013-2024

Global BIPV And BIOPV Market size is expected to reach USD 31.14 billion by 2024, according to a new report by Grand View Research, Inc. Rising adoption of energy generation by renewable sources without comprising on the aesthetic appeal of buildings is expected to drive growth over the forecast period.

Increasing demand for integrated installations is expected to be driven by the growing disposable income of the consumers. In addition, rising concerns regarding averse environmental impact due to the use of non-renewable energy sources are likely to account for the growth of the industry over the next eight years.

The industry has witnessed increased adoption of the environment-friendly energy sources by the multi-national corporations to limit the carbon footprints. In addition, growing subsidies and tax reductions offered by the national governments is expected to bolster the demand for the product.

The demand for the product has stemmed from the increased adoption of the integrated roofs, walls and windows owing to superior aesthetic properties. In addition, the industry has witnessed increased efforts towards the research & development activities leading to the development of magnetic nanoparticles incorporated solar cells, leading to an enhanced efficiency of the overall installation.

Access for full detail of the Report: http://www.grandviewresearch.com/industry-analysis/building-integrated-photovoltaics-bipv-market

Further key findings from the report suggest

• Building integrated roofs accounted for over 61% of the overall revenue due to superior efficiency of the roof-integrated systems. In addition, improved aesthetic appeal coupled with the ease of the integration of the solar energy harnessing systems for rooftop installations.
• Thin-film building integrated photovoltaics is expected to witness highest CAGR of over 20% from 2016 to 2024 due to superior integration with the building envelopes in comparison to the crystalline silicon.
• The thin film is expected to grow owing to significant technology advancements leading to improved performance efficiency as well as superior aesthetic appeal as compared to its counterparts.
• The market in Asia Pacific is expected to account for USD 7.48 Billion by 2024 due to increasing demand for the technology from the rapidly developing building and construction industry in the region.
• The companies in the market are involved in significant research & development activities to produce advanced products, in a bid to increase the market share. Heliatek GmbH introduced the organic building integrated photovoltaic cells, with high band gap resulting in superior efficiency.

View all the related reports from same Category: http://www.grandviewresearch.com/industry/renewable-energy 

Grand View Research has segmented the global BIPV market on the basis of technology, application, end-use and region:

• Technology Outlook (Revenue, USD Million, 2013 - 2024)
  • Crystalline Silicon (C-Si)
  • Thin Film
  • Others
• Application Outlook (Revenue, USD Million, 2013 - 2024)
• Roofs
• Walls
• Glass
• Facade
• Others
• Residential
• Commercial
• Industrial
• End-Use Outlook (Revenue, USD Million, 2013 - 2024)
• Regional Outlook (Revenue, USD Million, 2013 - 2024)

North America
§  U.S.
§  Canada
Europe
§  Germany
§  UK
Asia Pacific
§  China
§  India
Latin America
Middle East & Africa
 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-building-integrated-photovoltaics-bipv-market 

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Biosensors Market Qualitative Analysis by Industry overview, Trends, Market Drivers and Restraints

Global Biosensors Market is expected to reach USD 21.17 billion by 2020, according to a new study published by Grand View Research, Inc. Biosensors, owing to their capability to resolve various analytical issues in diverse areas such as medicine, pharmacology, food & agriculture safety and defense, are expected to witness a rapid growth in demand over the next six years. Increasing demand for specific detection techniques for early diagnosis in the healthcare sector is expected to drive the overall biosensors market during the forecast period. Furthermore, the expanding role of biosensors in the real world environment has led to a hike in R&D efforts globally.

Access for full detail of Report: http://www.grandviewresearch.com/industry-analysis/biosensors-market

Further key findings from the study suggest:

• Optical biosensors are identified as the most lucrative technology segment of this market and are expected to grow at a CAGR of over 7.0% during the forecast period. Growing use of these sensors in the field of environmental scanning is one of the key drivers of this market. The recent progress in optical biosensors has made them apt for environmental scanning wherein they are used for quantifying and characterizing environmental pollutants.
• Biosensors are mostly used in devices enabled with point of care testing. The biosensors based point of care testing segment accounted for over 40% of the end-use market in 2013. Moreover, rising demand for portable and integrated technologies that can be operated by untrained personnel outside conventional laboratories is expected to improve usage rates.
• North America accounted for more than 35% of the market in 2013. Biosensors witness the highest market penetration rates in this region owing to the presence of high procedure volumes supported by favourable government initiatives. Moreover, rapidly growing demand for point of care and home healthcare markets in the U.S. is expected to drive regional market growth during the forecast period.
• Asia Pacific has high future growth potential owing to the presence of large untapped opportunities in the emerging markets of India and China. Presence of favorable government initiatives aimed at improving environmental conditions and enhancing healthcare infrastructure in Japan and Australia are also expected to serve as a high impact rendering driver for this market.
• Key players of this market include Abbott Point of Care Inc., Roche, Lifescan Inc., Bayer AG, Medtronic Inc., Universal Biosensors, Siemens Healthcare and Nova Biomedical Corporation.

View all related reports from same Category: http://www.grandviewresearch.com/industry/medical-devices 

For the purpose of this study, Grand View Research has segmented the global biosensors market on the basis of application, technology and end-use:

Global Biosensors Application Outlook (Market Revenue in USD Million, 2012 – 2020)
    • Medical Applications
            • Cholesterol Testing
            • Blood Glucose Monitoring
            • Blood Gas Analyzer
            • Pregnancy Testing
            • Drug Discovery
            • Infectious Diseases
    • Food Toxicity Detection
    • Industrial Process Control (Bioreactor)
    • Agriculture
    • Environment
    • Others
Global Biosensors Technology Outlook (Market Revenue in USD Million, 2012 – 2020)
    • Thermal Biosensors
    • Electrochemical Biosensors
    • Piezoelectric Biosensors
    • Optical Biosensors
Global Biosensors End-use Outlook (Market Revenue in USD Million, 2012 – 2020)
    • Home Healthcare Diagnostics
    • Point of Care Testing
    • Food Industry
    • Research Laboratories
    • Security and Bio-Defense
Biosensors Regional Outlook (Market Revenue in USD Million, 2012 – 2020)
    North America
            • U.S.
            • Canada
    Europe
            • UK
            • Spain
            • Germany
    Asia Pacific
            • India
            • China
            • Japan
    RoW

Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-biosensors-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Autonomous Cars Market Analysis 2017 and Forecast up to 2024

Global Autonomous Cars Market is expected to reach 138,089 units by 2024, according to a new study by Grand View Research, Inc. The growing acceptance of semi-autonomous technologies, such as Adaptive Cruise Control (ACC), automatic parking, and forward collision avoidance, is anticipated to pave the way for the adoption of driverless automobiles over the next seven years. An upsurge in the demand for increased comfort and convenience, particularly in countries with an aging population, is expected to propel the driverless vehicles demand over the forecast period.

Features offered by the driverless cars primarily include a considerable decline in the frequency of road accidents caused due to human errors and easy commute. The self-driving technology exhibits a huge potential, owing to its capability to improve on-road safety, lower the energy consumption, and reduce congestion. Autonomous cars offer enhanced safety and efficiency over the conventional automobiles. Furthermore, driverless cars are anticipated to substantially impact the energy usage and reduce pollution. Autonomous vehicles can improve the fuel economy by accelerating & decelerating more effortlessly as compared to human drivers.

On the other hand, the high price of driverless vehicles may act as a hindrance for the market growth. The emotional implication of giving over personal safety and accountability to a machine may result in volatile public responses toward errors. The liability in case of accidents poses a key challenge for the government to address in advance to the adoption of autonomous cars. In addition to this, the penetration of driverless vehicles in taxis and other private point-to-point traveling industries is expected to increase the unemployment rate of drivers. Thus, the driverless vehicles are anticipated to witness mixed views. However, the increasing government support across the developed countries is expected to encourage the adoption of autonomous cars during the forecast period.

Access for full detail of Report: http://www.grandviewresearch.com/industry-analysis/driverless-cars-market

Further key findings from the study suggest:

• North America is anticipated to dominate the market with over 40% of the volume share in 2017.The region is further anticipated to witness a considerable growth over the next seven years. This growth is primarily attributed to the growing acceptance of the self-driving cars on the public roads of the U.S. Alphabet Inc. is the first company to demonstrate the prototype in the U.S. and has been testing its automobiles in different weather conditions since 2009. Furthermore, the growing government support in amending the current policy to accommodate the driverless feature in automobiles is expected to clear gateway for its adoption.
• Asia Pacific is expected to witness a sluggish growth as compared to North America and Europe. However, it is anticipated to grow substantially in the later phase of the forecast period due to the growing adoption of technologically advanced cars in China. In addition, the Japanese government has specifically laid down a plan for the successful self-driving vehicle deployment and is expected to catapult the product demand over the forecast period.
• For the initial adoption, the manufacturers are anticipated to target countries which have a lower population, including Singapore, the Netherlands, and Sweden, to better analyze the response toward the acceptance of the technology before deploying it in countries with a larger potential. This is ascribed to be a key factor for the considerable growth in the aforementioned countries. Furthermore, the Singaporean government has also proposed to build separate roads for driverless automobiles to accelerate the adoption.
• Europe is a key region for the deployment of self-driving vehicles, owing to the high consumer preference for technologically advanced products. This region is estimated to hold more than 35% of the volume share in 2017. This is attributed to the presence of players such as Volvo, Volkswagen, PSA Peugeot Citroën, and Fiat Chrysler Automobiles in Germany and the UK. The European countries also focus on reducing pollution.
• The prominent industry participants include Apple Inc., Baidu Inc., Alphabet Inc., Tesla Motors, Inc., The Volvo Group, and Nissan Motor Company Ltd. The system developers focus on collaborating with the Body in White (BIW) providers to reduce the additional cost.

View all related Reports from same Category: http://www.grandviewresearch.com/industry/automotive-and-transportation

Grand View Research has segmented the global autonomous cars/driverless cars market on the basis of region:

Autonomous Cars Regional Outlook (Units; 2017 - 2024)
North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Netherlands
• Sweden

Asia Pacific

• China
• Japan
• Australia
• Singapore

Latin America
Middle East & Africa
 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-driverless-cars-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com